Steward Partners Investment Advisory, LLC Voyager Therapeutics, Inc. Transaction History
Steward Partners Investment Advisory, LLC
- $8.95 Billion
- Q1 2024
A detailed history of Steward Partners Investment Advisory, LLC transactions in Voyager Therapeutics, Inc. stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 400 shares of VYGR stock, worth $3,092. This represents 0.0% of its overall portfolio holdings.
Number of Shares
400
Previous 400
-0.0%
Holding current value
$3,092
Previous $3,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding VYGR
# of Institutions
134Shares Held
34.2MCall Options Held
35.3KPut Options Held
63K-
Armistice Capital, LLC New York, NY4.67MShares$36.1 Million0.59% of portfolio
-
Black Rock Inc. New York, NY4.4MShares$34 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA3.92MShares$30.3 Million1.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.23MShares$25 Million0.0% of portfolio
-
Farallon Capital Management LLC San Francisco, CA2.29MShares$17.7 Million0.1% of portfolio
About Voyager Therapeutics, Inc.
- Ticker VYGR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,647,600
- Market Cap $299M
- Description
- Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...